Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cells

Yanwen Zhou1,2, Xinyu Chen1, Bo Kang1

  • 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China.

Insights

Octamer-binding transcription factor 4 variant A (OCT4A) is present in cancer cells, regulating genes crucial for tumor growth and migration. Its inhibition hinders cancer cell propagation and increases sensitivity to drugs.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Stem Cell Biology

Background:

  • Octamer-binding transcription factor 4 variant A (OCT4A) is a key regulator in pluripotent stem cells (PSCs) and reprogramming.
  • Its role in somatic cancer cells remains controversial and poorly understood.

Purpose of the Study:

  • To investigate the presence and function of OCT4A in somatic cancer cells.
  • To elucidate OCT4A's role in cancer cell biology and its potential as a therapeutic target.

Main Methods:

  • CRISPR-Cas9 gene editing
  • Specific PCR assays
  • Sensitive immunoassays
  • Mass spectrometry

Main Results:

  • Unequivocal evidence of full-length OCT4A transcripts and proteins in somatic cancer cells, predominantly nuclear localization.
  • Low-abundance OCT4A proteins regulate c-FOS transcription, impacting AP-1 signaling, self-renewal, and migration.
  • OCT4A knockout reduced c-FOS, impaired AP-1 signaling, decreased self-renewal and migration, retarded growth in vitro/in vivo, and enhanced drug sensitivity.

Conclusions:

  • Resolves controversy regarding OCT4A presence and function in cancer cells.
  • Reveals a fundamental role of OCT4A in regulating FOS/AP-1 signaling for cancer cell adhesion, migration, and propagation.
  • Suggests OCT4A as a potential therapeutic target for enhancing anti-cancer drug efficacy.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Master Transcription Regulators02:23

Master Transcription Regulators

2.8K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.4K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

2.6K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K